Skip to main content

Table 2 Clinicopathological characteristic of lung cancer patients for survival analysis

From: Incidence and survival analyses for occult lung cancer between 2004 and 2015: a population-based study

 

All patients

(N = 52,472)

Variables

N

%

Sex

 Male

26,858

51.2

 Female

25,614

48.8

Race

 Non-Hispanic whites

43,818

83.5

 Non-Hispanic others

8654

16.5

Age (year)

  ≤ 68

23,070

44.0

  > 68

29,402

56.0

 Median (range)

70 (18–100)

Grade

 Well

5579

10.6

 Moderate

16,142

30.8

 Poor

16,855

32.1

 Undifferentiated

1745

3.3

 Unknown

12,151

23.2

Tumor Location

 Main bronchus

1271

2.4

 Upper lobe

30,463

58.0

 Middle lobe

2423

4.6

 Lower lobe

15,734

30.0

 Overlapping lesion of lung

607

1.2

 Unknown

1974

3.8

Radiotherapy

 No

37,612

71.7

 Yes

14,508

27.6

 Unknown

352

0.7

Chemotherapy

 No

39,127

74.6

 Yes

13,345

25.4

Marital status

 Married

27,089

51.6

 Non-married

23,504

44.8

 Unknown

1879

3.6

Surgical treatment

 None

22,136

42.2

 Limited resection

5784

11.0

 Lobectomy

23,228

44.2

 Pneumonectomy

984

1.9

 Unknown surgical approach

29

0.1

 Unknown

311

0.6

Histological subtypes

 Squamous cell carcinoma

16,691

31.8

 Adenocarcinoma

23,406

44.6

 Non-squamous and non-adenocarcinoma NSCLC

5128

9.8

 Small-cell carcinoma

2583

4.9

 Unknown non-sarcoma carcinoma

477

0.9

 Unknown NSCLC

4187

8.0

T classification

 T1a

1752

3.3

 T1b

9439

18.0

 T1c

8412

16.1

 T2a

11,509

21.9

 T2b

3784

7.2

 T3

4180

8.0

 T4

11,043

21.0

 Tx (occult)

2353

4.5

  1. NSCLC non-small cell lung cancer